Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Abingdon Health's share price for the quarter that ended in Dec. 2023 was $0.07. Abingdon Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 121.72 Mil. Therefore, Abingdon Health's market cap for the quarter that ended in Dec. 2023 was $8.52 Mil.
Abingdon Health's quarterly market cap
stayed the same
from Dec. 2022 ($8.52 Mil) to Jun. 2023 ($8.52 Mil) and
stayed the same
from Jun. 2023 ($8.52 Mil) to Dec. 2023 ($8.52 Mil).
Abingdon Health's annual market cap
stayed the same
from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then
increased
from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($8.52 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Abingdon Health's Enterprise Value for Today is $16.54 Mil.
Abingdon Health Market Cap Historical Data
The historical data trend for Abingdon Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Abingdon Health's Market Cap
For the Diagnostics & Research subindustry, Abingdon Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abingdon Health's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Abingdon Health's Market Cap falls into.
Abingdon Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Abingdon Health's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abingdon Health (OTCPK:ABDXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Abingdon Health Market Cap Related Terms
Thank you for viewing the detailed overview of Abingdon Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Abingdon Health (Abingdon Health) Business Description
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABDXF has been successfully added to your 